Accès ouvert
2026
preprint
OpenAlex
Hao Chen, Zuyuan Shen, Qi Qu, Jiliang Chen et autres
Abstract Molecular glue degraders (MGD), a new drug modality that utilizes the natural proteasomal degradation machinery in cells for target protein degradation, is drawing great attraction from the pharmaceutical industry in recent years. However, the pace of MGD molecule discovery can be …
cn, us
(code pays fourni par la source)
2026
article
OpenAlex
Fei Yu, Qing Jiang, Xun Chong, Lingkai Zhang et autres
cn
(code pays fourni par la source)
2025
book-chapter
OpenAlex
Hui Zhou, Wenji Su, Liyi Fu, Dean Shuailin Chen et autres
us, cn
(code pays fourni par la source)
2025
article
OpenAlex
Philipp Bittner, Andreas Gloger, Julian Alexander Harrison, Adam Pruška et autres
DNA-encoded libraries have become widely used in drug discovery, and several different setups to link chemical compounds to DNA have been employed in the field, including single-stranded and double-stranded DNA tags as well as a variety of linker chemistries. In our previous …
ch
(code pays fourni par la source)
2025
article
OpenAlex
Yihui Xie, Min-Chi Huang, Yanfen Jiang, Xiaoming Miao et autres
One-bead-one-compound (OBOC) DNA-encoded library (DEL) enables high-throughput activity-based screening to find novel hits against pharmaceutical targets. Herein, we developed solid-phase and DNA-compatible conditions to implement the three-component Van Leusen reaction (imidazole formation) for OBOC DELs. High-throughput validation was conducted (employing every potential …
cn, de, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Philipp Bittner, Andreas Gloger, Michelle Keller, Sebastian Oehler et autres
DNA-encoded Library (DEL) Technology has become a workhorse of drug development, is widely employed in an industrial and academic setting, and an increasing number of drugs developed by DEL technology have entered clinical stage development. While up to billions of compounds can …
ch
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Philipp Bittner, Andreas Gloger, Michelle Keller, Sebastian Oehler et autres
Zusammenfassung Die DNA‐encoded Library (DEL) Technologie hat sich als zentrales Instrument der Wirkstoffentwicklung etabliert und wird sowohl in der Industrie als auch in der akademischen Forschung breit eingesetzt. Eine zunehmende Anzahl von durch DEL entwickelten Wirkstoffen befindet sich in der klinischen Entwicklung. …
ch, iq
(code pays fourni par la source)
2025
article
OpenAlex
Gaonan Wang, Xiaona Zhang, Hui Zhu, Xiaodong Shi et autres
DNA-encoded chemical library (DECL) technology is recognized as a robust screening platform for drug discovery. Developing new DNA-compatible reactions is crucial for expanding the chemical space of DECLs. Cyclization reactions, particularly those involving the formation of heterocycles, offer unique and efficient methods …
cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Zhongyao Ma, Bin Zou, Jiannan Zhao, Rui Zhang et autres
To date, RNA-targeted chemical matter is under explored due to a lack of robust screening assays. In this study, we present a novel RNA-targeted small molecule screening approach using a specialized DNA-encoded library (DEL). Our findings reveal that the specialized DEL library, …
cn, us
(code pays fourni par la source)
2024
article
OpenAlex
Yunhui Huang, Fujun Niu, Peifeng He, Weidong Pan et autres
cn
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Zhongyao Ma, Bin Zou, Jiannan Zhao, Rui Zhang et autres
To date, RNA-targeted chemical matter is under explored due to a lack of robust screening assays. In this study, we present a novel RNA-targeted small molecule screening approach using a specialized DNA-encoded library (DEL). Our findings reveal that the specialized DEL library, …
cn, us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Shuai Han, Xinyun Guo, Min Wang, Huan Liu et autres
High Resolution Image Download MS PowerPoint Slide DNA-encoded library (DEL) technology, especially when combined with machine learning (ML), is a powerful method to discover novel inhibitors. DEL-ML can expand a larger chemical space and boost cost-effectiveness during hit finding. Heme oxygenase-1 (HO-1), …
cn, us
(code pays fourni par la source)